Shilpi Majumdar

1 week ago | today.westlaw.com | Shilpi Majumdar |Sneha K |Bill Berkrot |Mariam Sunny

(Reuters) -The U.S. Centers for Disease Control and Prevention's panel of outside experts on Wednesday recommended the use of respiratory syncytial virus vaccines in younger adults who are at increased risk of severe illness from the virus.

1 week ago | dagenspharma.dk | Sriparna Roy |Shailesh Kuber |Shilpi Majumdar

The logo of Danish drugmaker Novo Nordisk in their offices in Hillerod, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo April 14 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain in the United States. The country's health regulator seized the counterfeit injections on April 9 and is investigating them.

1 week ago | gurutrade.com | Arasu Kannagi Basil |Shilpi Majumdar

April 14 (Reuters) - KKR will buy a joint venture of S&P Global and CME Group in a $3.1 billion deal, in the U.S. private equity firm's second acquisition in less than a week despite a tariff whiplash slowing the pace of dealmaking activity.

2 weeks ago | gurutrade.com | Ragini Mathur |Shilpi Majumdar

FTSE 100 up 1.4%, FTSE 250 rises 2.5% Aerospace and defence index gains over 5%, led by Babcock Energy index climbs 3% as oil prices rebound April 8 (Reuters) - Britain's main indexes recovered from their lowest levels in more than a year on Tuesday, as investors look for any indication of Washington softening its stance on the aggressive tariffs that have roiled global markets over the last few days.

2 weeks ago | gurutrade.com | Ragini Mathur |Shilpi Majumdar

FTSE 100 down 3.8%, FTSE 250 falls 4% BP shares drop as Chair Helge Lund decides to step down UK banks and mining stocks hit by tariff concerns Utilities gain as bond proxy amid market turmoil April 4 (Reuters) - UK shares fell sharply on Friday and are poised to end the week with substantial losses, as recession fears intensified after China retaliated against U.S. President Donald Trump's announcement of sweeping tariffs.